Superantigens related to Kawasaki syndrome

Springer Seminars in Immunopathology

Volumn 17, Issue 4, 1996, Pages 385-396

  Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; SUPERANTIGEN;

IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; REVIEW; TOXIC SHOCK SYNDROME;

HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME; SUPERANTIGENS;

EID: 0029983914     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01795136     Document Type: Review

References (48)

1. Newburger JW, Burns JC (1989) Kawasaki Syndrome. Cardiol Clin 7:453
2. Leung DYM (1993) Kawasaki disease. Curr Opin Rheumatol 5:41
3. Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Aererugi 16:178
4. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, Mason WH, Meissner HC, Rowley AH, Shulman ST, Reddy V, Sundel RP, Wiggins JW, Colton T, Melish MF, Rosen FS (1986) The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J Med 315:341
5. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamuira T, Hirose O, Manahe Y, and Yokoyama T (1984) High dose intravenous gammaglobulin for Kawasaki disease. Lancet II:1055
6. Newburger JW, Takahashi M., Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, Mason WH, Meissner HC, Rowley AH, Shulman ST, Reddy V, Sundel RP, Wiggins JW, Colton T, Melish ME, Rosen FS (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633
7. American Heart Association Committee on Rheumatic Fever (1990) Diagnostic Guidelines for Kawasaki Disease. JAMA 44:1218
8. Yanagawa H, Nakamura Y, Yashiro M, Fujita Y, Nagai M, Kawasaki T, Aso S, Imada Y, Shigematsu I (1988) A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan. J Infect Dis 158:1296
9. Tizard EJ, Suzuki A, Levin M, Dillon MJ (1991) Clinical aspects of 100 patients with Kawasaki disease. Arch Dis Child 66:185
10. Suzuki A, Kamiya T, Kuwahara N, Ono Y, Kohata T, Takahash O, Kimma K, Takamiya M (1986) Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 7:3
11. Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75:387
12. Tatara K, Kusakawa S (1987) Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiograph, study. J Pediatr 111:705
13. Tanaka N, Naoe S, Masuda H, Ueno T (1986) Pathological study of sequelae of Kawasaki disease (MCLS). With special reference to the heart and coronary arterial lesions. Acta Pathol Jpn 36:1513
14. Meissner HC, Schlievert PM, Leung DYM (1995) The mechanisms of immunoglobulin action: observations on Kawasaki syndrome and RSV prophylaxis. Immunol Rev 139:109
15. Terai M, Kohno Y, Namba M, Umeoniya T, Niwa K, Nakajima H, Mikata A (1990) Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum Pathol 21:231
16. Leung DYM, Chu ET, Wood N, Grady S, Meade R, Geha RS (1983) Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol 130:2002
17. Leung D, Cotran R, Kurt-Jones E, Burns J, Newburger J, Pober J (1989) Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet II:1298
18. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, Kato H, Yabuta K (1988) Peripheral blood monocyte/macrophage and serum tumor necrosis factor in Kawasaki disease. Clin Exp Immunol 48:247
19. Ueno Y, Takano N, Kanegane H, Yokoi T, Yachie A, Miyawaki T, Taniguchi N, (1989) The acute phase nature of interleukin 6: studied in Kawasaki disease and other febrile illness. Clin Exp Immunol 76:337
20. Lang BA, Silverman ED, Laxer RM, Lau AS (1989) Spontaneous tumor necrosis factor production in Kawasaki disease. J Pediatr 115:939
21. Leung DYM, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, Pober JS (1986) Two monokines, interleukin-1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 164:1958
22. Leung D, Collins T, Lapierre L, Geha R, Pober J (1986) IgM antibodies in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by γ interferon. J Clin Invest 77:1428
23. Leung DYM, Burns J, Newburger J, Geha RS (1987) Reversal of immunoregulatory abnormalities in Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest 79:468
24. Rauch AM (1987) Kawasaki syndrome: review of new epidemiologic and laboratory developments. Pediatr Infect Dis 6:1016
25. Kotzin BL, Leung DYM, Kappler J, Marrack P (1993) Superantigens and human disease. Adv Immunol 54:99
26. Fast DJ, Schlievert PM, Nelson RD (1989) Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immunol 57:291
27. Herman A, Croteau G, Sekaly R.-P, Kappler J, Marrack P (1990) HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J Exp Med 172:709
28. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DYM (1992) Selective expansion of T cells expressing T cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA 89:4066
29. Choi Y, Lafferty JA, Clements JR, Todd JK, Gelfand EW, Kappler J, Marrack P, Kotzin BL (1990) Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J Exp Med 172:981
30. Pietra BA, De Inocencio J, Giannini EH, Hirsch R (1994) TCR Vβly repertoire and T cell activation markers in Kawasaki disease. J Immunol 153:1881
31. McCormack J, Callahan JE, Kappler J, Marrack PC (1993) Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 150:3785
32. Curtis N, Zheng R, Lamb JR, Levin M (1995) Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child 72:308
33. Leung DYM, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM,Picker L J (1995) Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen (CLA). J Exp Med 181:747
34. Abe J, Kotzin BL, Meissner HC, Melish ME, Masato T, Fulton D, Romagne F, Malissen B, Leung DYM (1993) Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med 177:791
35. Leung DYM, Giorno R, Kazemi LV, Flynn PA, Bussel JB (1995) Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol 153:5018
36. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM (1993) Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 342:1385
37. Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248:705
38. Stohl W, Elliott JE, Linsley PS (1994) Human T cell-dependent B cell differentiation induced by staphylococcal superantigens. J Immunol 153:117
39. Hofer MF, Lester MR, Schlievert PM, Leung DYM (1995) Effect of bacterial toxins on IgE synthesis. Clin Exp Allergy (in press)
40. Schlievert PM, Blomster DA (1983) Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis 147:236
41. Todd JK, Franco-Buff A, Lawellin DW, Vasil ML (1984) Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome. Infect Immun 45:339
42. Kass EH, Schlievert PM, Parsonnet J, Mills JT (1988) Effect of magnesium on production of toxic-shock-syndrome toxin-1: a collaborative study. J Infect Dis 158:44
43. Quimby FW, Nguyen HT (1985) Animal studies of toxic shock syndrome. Crit Rev Microbiol 12:1
44. Rowley AH, Shulman ST (1991) Current therapy for acute Kawasaki syndrome. J Pediatr 118:987
45. Takei S, Arora YK, Walker SM (1993) Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 91:602
46. Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW (1993) Gamma globulin retreatment in Kawasaki disease. J Pediatr 123:657
47. Gelfand EW (1989) Intevention in autoimmune disorders: creation of a niche for intravenous γ-globulin therapy. Clin Immunol Immunopathol 53:S1.
48. Vergeront JM, Stolz SJ, Crass BA, Nelson DB, Davis JP, Bergdoll MS (1983) Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic shock syndrome. J Infect Dis 148:692